Global Lipid-lowering Agent Market Professional Survey Report 2017

August 2017 | 112 pages | ID: GDD0C0CAE83EN
QYResearch

Abstracts

This report studies Lipid-lowering Agent in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Merck
• Teva
• Amgen
• Abbott
• AstraZeneca
• Novartis
• SUN Pharma
• Torrent Pharmaceuticals
• GlaxoSmithKline
• HanAll BioPharma
• JX Pharmaceuticals
• Aurobindo Pharma
• Abbvie
• Cerenis Therapeutics

By types, the market can be split into

• Niaci
• Acipimox
• Fibrates
• Others

By Application, the market can be split into

• Hospitals
• Clinics
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Lipid-lowering Agent Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF LIPID-LOWERING AGENT

1.1 Definition and Specifications of Lipid-lowering Agent
  1.1.1 Definition of Lipid-lowering Agent
  1.1.2 Specifications of Lipid-lowering Agent
1.2 Classification of Lipid-lowering Agent
  1.2.1 Niaci
  1.2.2 Acipimox
  1.2.3 Fibrates
  1.2.4 Others
1.3 Applications of Lipid-lowering Agent
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF LIPID-LOWERING AGENT

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Lipid-lowering Agent
2.3 Manufacturing Process Analysis of Lipid-lowering Agent
2.4 Industry Chain Structure of Lipid-lowering Agent

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF LIPID-LOWERING AGENT

3.1 Capacity and Commercial Production Date of Global Lipid-lowering Agent Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Lipid-lowering Agent Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Lipid-lowering Agent Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Lipid-lowering Agent Major Manufacturers in 2016

4 GLOBAL LIPID-LOWERING AGENT OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Lipid-lowering Agent Capacity and Growth Rate Analysis
  4.2.2 2016 Lipid-lowering Agent Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Lipid-lowering Agent Sales and Growth Rate Analysis
  4.3.2 2016 Lipid-lowering Agent Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Lipid-lowering Agent Sales Price
  4.4.2 2016 Lipid-lowering Agent Sales Price Analysis (Company Segment)

5 LIPID-LOWERING AGENT REGIONAL MARKET ANALYSIS

5.1 North America Lipid-lowering Agent Market Analysis
  5.1.1 North America Lipid-lowering Agent Market Overview
  5.1.2 North America 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.1.4 North America 2016 Lipid-lowering Agent Market Share Analysis
5.2 China Lipid-lowering Agent Market Analysis
  5.2.1 China Lipid-lowering Agent Market Overview
  5.2.2 China 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.2.4 China 2016 Lipid-lowering Agent Market Share Analysis
5.3 Europe Lipid-lowering Agent Market Analysis
  5.3.1 Europe Lipid-lowering Agent Market Overview
  5.3.2 Europe 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.3.4 Europe 2016 Lipid-lowering Agent Market Share Analysis
5.4 Southeast Asia Lipid-lowering Agent Market Analysis
  5.4.1 Southeast Asia Lipid-lowering Agent Market Overview
  5.4.2 Southeast Asia 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.4.4 Southeast Asia 2016 Lipid-lowering Agent Market Share Analysis
5.5 Japan Lipid-lowering Agent Market Analysis
  5.5.1 Japan Lipid-lowering Agent Market Overview
  5.5.2 Japan 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.5.4 Japan 2016 Lipid-lowering Agent Market Share Analysis
5.6 India Lipid-lowering Agent Market Analysis
  5.6.1 India Lipid-lowering Agent Market Overview
  5.6.2 India 2012-2017E Lipid-lowering Agent Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Lipid-lowering Agent Sales Price Analysis
  5.6.4 India 2016 Lipid-lowering Agent Market Share Analysis

6 GLOBAL 2012-2017E LIPID-LOWERING AGENT SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Lipid-lowering Agent Sales by Type
6.2 Different Types of Lipid-lowering Agent Product Interview Price Analysis
6.3 Different Types of Lipid-lowering Agent Product Driving Factors Analysis
  6.3.1 Niaci of Lipid-lowering Agent Growth Driving Factor Analysis
  6.3.2 Acipimox of Lipid-lowering Agent Growth Driving Factor Analysis
  6.3.3 Fibrates of Lipid-lowering Agent Growth Driving Factor Analysis
  6.3.4 Others of Lipid-lowering Agent Growth Driving Factor Analysis

7 GLOBAL 2012-2017E LIPID-LOWERING AGENT SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Lipid-lowering Agent Consumption by Application
7.2 Different Application of Lipid-lowering Agent Product Interview Price Analysis
7.3 Different Application of Lipid-lowering Agent Product Driving Factors Analysis
  7.3.1 Hospitals of Lipid-lowering Agent Growth Driving Factor Analysis
  7.3.2 Clinics of Lipid-lowering Agent Growth Driving Factor Analysis
  7.3.3 Others of Lipid-lowering Agent Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF LIPID-LOWERING AGENT

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.2 Merck
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Merck 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.3 Teva
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Teva 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Teva 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.4 Amgen
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Amgen 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Amgen 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.5 Abbott
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Abbott 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Abbott 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.6 AstraZeneca
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 AstraZeneca 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 AstraZeneca 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.7 Novartis
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novartis 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novartis 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.8 SUN Pharma
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 SUN Pharma 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 SUN Pharma 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.9 Torrent Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Torrent Pharmaceuticals 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Torrent Pharmaceuticals 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.10 GlaxoSmithKline
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 GlaxoSmithKline 2016 Lipid-lowering Agent Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 GlaxoSmithKline 2016 Lipid-lowering Agent Business Region Distribution Analysis
8.11 HanAll BioPharma
8.12 JX Pharmaceuticals
8.13 Aurobindo Pharma
8.14 Abbvie
8.15 Cerenis Therapeutics

9 DEVELOPMENT TREND OF ANALYSIS OF LIPID-LOWERING AGENT MARKET

9.1 Global Lipid-lowering Agent Market Trend Analysis
  9.1.1 Global 2017-2022 Lipid-lowering Agent Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Lipid-lowering Agent Sales Price Forecast
9.2 Lipid-lowering Agent Regional Market Trend
  9.2.1 North America 2017-2022 Lipid-lowering Agent Consumption Forecast
  9.2.2 China 2017-2022 Lipid-lowering Agent Consumption Forecast
  9.2.3 Europe 2017-2022 Lipid-lowering Agent Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Lipid-lowering Agent Consumption Forecast
  9.2.5 Japan 2017-2022 Lipid-lowering Agent Consumption Forecast
  9.2.6 India 2017-2022 Lipid-lowering Agent Consumption Forecast
9.3 Lipid-lowering Agent Market Trend (Product Type)
9.4 Lipid-lowering Agent Market Trend (Application)

10 LIPID-LOWERING AGENT MARKETING TYPE ANALYSIS

10.1 Lipid-lowering Agent Regional Marketing Type Analysis
10.2 Lipid-lowering Agent International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Lipid-lowering Agent by Region
10.4 Lipid-lowering Agent Supply Chain Analysis

11 CONSUMERS ANALYSIS OF LIPID-LOWERING AGENT

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL LIPID-LOWERING AGENT MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Lipid-lowering Agent
Table Product Specifications of Lipid-lowering Agent
Table Classification of Lipid-lowering Agent
Figure Global Production Market Share of Lipid-lowering Agent by Type in 2016
Figure Niaci Picture
Table Major Manufacturers of Niaci
Figure Acipimox Picture
Table Major Manufacturers of Acipimox
Figure Fibrates Picture
Table Major Manufacturers of Fibrates
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Lipid-lowering Agent
Figure Global Consumption Volume Market Share of Lipid-lowering Agent by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Lipid-lowering Agent by Regions
Figure North America Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Figure China Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Figure Europe Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Figure Southeast Asia Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Figure Japan Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Figure India Lipid-lowering Agent Market Size (Million USD) (2012-2022)
Table Lipid-lowering Agent Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Lipid-lowering Agent in 2016
Figure Manufacturing Process Analysis of Lipid-lowering Agent
Figure Industry Chain Structure of Lipid-lowering Agent
Table Capacity and Commercial Production Date of Global Lipid-lowering Agent Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Lipid-lowering Agent Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Lipid-lowering Agent Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Lipid-lowering Agent Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Lipid-lowering Agent 2012-2017
Figure Global 2012-2017E Lipid-lowering Agent Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Lipid-lowering Agent Market Size (Value) and Growth Rate
Table 2012-2017E Global Lipid-lowering Agent Capacity and Growth Rate
Table 2016 Global Lipid-lowering Agent Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Lipid-lowering Agent Sales (K Units) and Growth Rate
Table 2016 Global Lipid-lowering Agent Sales (K Units) List (Company Segment)
Table 2012-2017E Global Lipid-lowering Agent Sales Price (USD/Unit)
Table 2016 Global Lipid-lowering Agent Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure North America 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure North America 2016 Lipid-lowering Agent Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure China 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure China 2016 Lipid-lowering Agent Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure Europe 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure Europe 2016 Lipid-lowering Agent Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure Southeast Asia 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure Southeast Asia 2016 Lipid-lowering Agent Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure Japan 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure Japan 2016 Lipid-lowering Agent Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Lipid-lowering Agent 2012-2017E
Figure India 2012-2017E Lipid-lowering Agent Sales Price (USD/Unit)
Figure India 2016 Lipid-lowering Agent Sales Market Share
Table Global 2012-2017E Lipid-lowering Agent Sales (K Units) by Type
Table Different Types Lipid-lowering Agent Product Interview Price
Table Global 2012-2017E Lipid-lowering Agent Sales (K Units) by Application
Table Different Application Lipid-lowering Agent Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Lipid-lowering Agent Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Lipid-lowering Agent Business Region Distribution
Table Teva Information List
Table Product A Overview
Table Product B Overview
Table 2015 Teva Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Lipid-lowering Agent Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Lipid-lowering Agent Business Region Distribution
Table Abbott Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Lipid-lowering Agent Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Lipid-lowering Agent Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Lipid-lowering Agent Business Region Distribution
Table SUN Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 SUN Pharma Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 SUN Pharma Lipid-lowering Agent Business Region Distribution
Table Torrent Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Torrent Pharmaceuticals Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Torrent Pharmaceuticals Lipid-lowering Agent Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Lipid-lowering Agent Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Lipid-lowering Agent Business Region Distribution
Table HanAll BioPharma Information List
Table JX Pharmaceuticals Information List
Table Aurobindo Pharma Information List
Table Abbvie Information List
Table Cerenis Therapeutics Information List
Figure Global 2017-2022 Lipid-lowering Agent Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Lipid-lowering Agent Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Lipid-lowering Agent Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Lipid-lowering Agent Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Lipid-lowering Agent by Type 2017-2022
Table Global Consumption Volume (K Units) of Lipid-lowering Agent by Application 2017-2022
Table Traders or Distributors with Contact Information of Lipid-lowering Agent by Region